Gastroesophageal Reflux Disease Devices Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Market Overview

The Gastroesophageal Reflux Disease (GERD) Devices Market is projected to increase from USD 1,187.3 million in 2024 to an estimated USD 1,575.57 million by 2032, representing a compound annual growth rate (CAGR) of 3.6% from 2024 to 2032.

Market expansion is primarily driven by the rising prevalence of GERD, attributed to lifestyle shifts, poor dietary patterns, and the growing incidence of obesity. The increasing geriatric population—more prone to chronic acid reflux—further amplifies demand. In parallel, the shift toward minimally invasive treatment methods, including magnetic sphincter augmentation and endoscopic procedures, is displacing traditional surgical approaches. Technological advancements, such as wireless pH monitoring and impedance-pH probes, are enhancing the precision and comfort of diagnostics, facilitating early intervention and improved treatment efficacy. In addition, growing public awareness of GERD complications, favorable policy support, and the introduction of cost-effective therapeutic options are collectively contributing to the market’s sustained growth trajectory.

Market Drivers

Innovation in GERD Diagnostics and Treatment Solutions

Technological advancements are significantly accelerating the adoption of GERD management devices. Innovations in diagnostics—such as wireless pH monitoring and impedance-pH systems—offer minimally invasive, accurate, and patient-centric approaches for assessing disease severity and guiding personalized treatment plans. For instance, Medtronic’s Bravo™ system enables 48-hour wireless pH monitoring, enhancing diagnostic comfort and accuracy. On the therapeutic front, non-surgical alternatives like magnetic sphincter augmentation and endoscopic devices are increasingly favored due to faster recovery and sustained symptom relief. These technologies are improving clinical outcomes and decreasing reliance on long-term medication, thus appealing to both patients and healthcare providers.

Market Challenges Analysis

Cost Barriers Limiting Access to Advanced GERD Solutions

A major obstacle to market growth is the high cost of advanced GERD diagnostic and treatment technologies. Devices such as wireless pH monitors, magnetic sphincter systems, and endoscopic therapies involve significant development and deployment expenses. These elevated costs limit affordability, particularly in emerging markets and among underinsured populations. As a result, access to effective GERD interventions remains uneven, curbing broader market penetration and creating disparities in treatment availability.

Market Segmentation

By Product:

Diagnostic Devices:

Manometry Systems

PH Monitoring Systems

Esophagoscopes and Gastroscopes

Treatment Devices:

Ultrasonic Surgical Endostaplers

Fundoplication Devices

Sphincter Augmentation Devices

Radiofrequency Ablation Devices

By Procedure:

Diagnostic Procedures

Fundoplication Procedures

Radiofrequency Thermal Ablation

Magnetic Sphincter Augmentation

By End User:

Hospitals

Diagnostic Centers

Ambulatory Surgical Centers

By Region:

North America:

U.S.

Canada

Mexico

Europe:

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific:

China

Japan

India

South Korea

Southeast Asia

Rest of Asia Pacific

Latin America:

Brazil

Argentina

Rest of Latin America

Middle East & Africa:

GCC Countries

South Africa

Rest of Middle East and Africa

Key Player Analysis

Diversatek Inc.

EndoGastric Solutions

Fujifilm Holdings Corporation

KARL STORZ SE & Co. KG

Medigus Ltd.

Medtronic Plc

Olympus Corporation

Pentax Medical